ARCT

ARCT R&D Expense Growth

-42.50%Fiscal year

Period ending:

ARCT FY R&D Growth (YoY)%
ARCT FY R&D Growth (YoY)862.08%-153.37%
2011-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods. Dates are period ends; a fiscal year may differ from a calendar year. Growth compares with the corresponding period one year earlier.

ARCT r&d expense growth history

Year-over-year research & development expense growth. The available annual fiscal periods series contains 15 observations from Dec 31, 2011 to Dec 31, 2025.

Arcturus Therapeutics Holdings Inc R&D Expense Growth — Annual fiscal periods
Period endingR&D Expense Growth
-42.5014%
1.5734%
30.0384%
-14.9683%
200.3838%
71.956%
98.0921%
6.6843%
-13.4468%
36.6243%
-46.3812%
255.293%
763.8142%
-55.1043%
0%

Compare r&d expense growth

All ARCT financial metrics · ARCT stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.